Open AccessTHE DYNAMICS OF MARKERS OF FIBROSIS WITH THE FEATURES OF METABOLIC PHENOTYPES IN PATIENTS WITH MYOCARDIAL INFARCTION
Author(s) -
А. В. Осокина,
Осокина Анастасия Вячеславовна,
В. Н. Каретникова,
Каретникова В. Н,
О. М. Поликутина,
Поликутина О. М,
О. В. Груздева,
Груздева О. В,
T. P. Solodilova,
Солодилова Т. П,
С Н Косарева,
Косарева С. Н,
О. Л. Барбараш,
Барбараш О. Л
Publication year - 2019
Publication title -
rossijskij medicinskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2412-9100
pISSN - 0869-2106
DOI - 10.18821/0869-2106-2019-25-3-151-157
Subject(s) - medicine , myocardial infarction , cardiology , myocardial fibrosis , fibrosis , ejection fraction , procollagen peptidase , overweight , anamnesis , obesity , heart failure
The features of the dynamics of serum markers of fibrosis, myocardial remodeling and progression of chronic insufficiency: C-terminal propeptide procollagen type I (PICP) and N-terminal propeptide procollagen type III (PIIINP) in patients with ST-segment elevation myocardial infarction were evaluated taking into account the peculiarities of the metabolic phenotype of patients. The study included 83 patients with left ventricular ejection fraction ≥50% of 120 patients admitted to the hospital with a diagnosis of ST-segment elevation myocardial infarction. Depending on the metabolic phenotype, the patients were divided into two groups: a group of 23 patients with normal body weight and a group of 60 patients with overweight and obesity of varying severity. The results indicate the relationship of serum markers of fibrosis of the myocardium with echocardiogram indicators, and myocardial remodeling in patients with myocardial infarction with ST-segment elevation. Isolation of patients with normal weight showed a general tendency to reduce the concentration of fibrosis markers regardless of the duration of the disease. The reverse trend allowed us to observe the selection of a group of patients with overweight or obesity. The obtained significant correlation between markers of myocardial fibrosis, data, echocardiogram, and anamnesis.